SEC Form 3 · accession 0001209191-16-111303
Eiger BioPharmaceuticals, Inc. · EIGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nina S Kjellson
Director · 10% Owner
Period of report
Mar 22, 2016
Accepted (ET)
Mar 31, 2016 · 8:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,599,593 | I | By limited partnership |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held by InterWest Partners X, LP., InterWest Management Partners X, LLC has sole voting and investment control over the shares owned by InterWest X, LP. The managing directors and venture members of InterWest Management Partners X, LLC have shared voting and investment control over the shares owned by InterWest Partners X, LP. The reporting person is a member of InterWest Management Partners X, LLC and disclaims beneficial ownership of the shares owned by InterWest Partners X, LP, except to the extent of her pro rata partnership interest therein.